Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?
, , und
28. März 2022
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 28. März 2022
Seitenbereich: 259 - 266
Eingereicht: 21. Okt. 2021
Akzeptiert: 31. Jan. 2022
DOI: https://doi.org/10.2478/raon-2022-0010
Schlüsselwörter
© 2022 Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Borowicz, Dorota Maria
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Skrobała, Agnieszka
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland
Kruszyna-Mochalska, Marta
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland
Malicki, Julian
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland